版本:
中国

BRIEF-Aerie Pharmaceuticals raises $125 mln

May 26 Aerie Pharmaceuticals Inc:

* Aerie Pharmaceuticals raises $125 million in ATM sales and upsized follow-on offering

* Aerie Pharmaceuticals -priced registered underwritten public offering of $75 million of shares of its common stock at a price to public of $53.75 per share

* Aerie Pharmaceuticals-to use proceeds to fund expansion of commercialization programs in north america for rhopressa, roclatan, among others

* Aerie Pharmaceuticals- $125 million is in addition to $50 million of shares sold through completion with Cantor Fitzgerald & Co Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐